8-K Announcements
6Material company update
May 5, 2026·SEC
Material company update
Feb 23, 2026·SEC
Material company update
Dec 8, 2025·SEC
ProAssurance Corporation(PRA)Earnings, Financials & Key Ratios
PRA•NYSE•Insurance & Managed Care
$24.60
$1.27B mkt cap·24.8× P/E·Price updated May 6, 2026
SectorFinancial ServicesIndustryProperty & Casualty InsuranceSub-IndustrySpecialty and excess surplus insurers
AboutProAssurance Corporation, through its subsidiaries, provides property and casualty insurance, and reinsurance products in the United States. The company operates through Specialty Property and Casualty, Workers' Compensation Insurance, Segregated Portfolio Cell Reinsurance, and Lloyd's Syndicate segments. It offers professional liability insurance for healthcare providers and institutions, and attorneys; liability insurance for medical technology and life sciences risks; and workers' compensation insurance, such as guaranteed cost policies, policyholder dividend policies, retrospectively rated policies, and deductible policies, as well as alternative market solutions that include program design, fronting, claims administration, risk management, SPC rental, asset management, and SPC management services for individual companies, agencies, groups, and associations. The company also participates in Lloyd's of London Syndicate 1729, which underwrites property and casualty insurance, and reinsurance. It markets its products through independent agencies and brokers, as well as an internal sales force. The company was founded in 1976 and is headquartered in Birmingham, Alabama.Show more
- Revenue$1.1B-2.7%
- Combined Ratio93.44%-1.0%
- Net Income$51M-3.5%
- Return on Equity3.99%-12.4%
- Medical Cost Ratio60.6%-21.9%
- Operating Margin6.56%+17.4%
- Net Margin4.64%-0.8%
- ROA0.92%-1.8%
- Equity / Assets24.77%+14.9%
- Book Value per Share26.11+11.4%
- Tangible BV/Share23.95+7.5%
- Debt/Equity0.32-12.4%
PRA Key Insights
ProAssurance Corporation (PRA) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Profitable underwriting: 93.4% combined ratio
- ✓Trading near 52-week high
- ✓Trading at only 0.9x book value
✗Weaknesses
- ✗Weak 3Y average ROE of 1.7%
- ✗Weak Piotroski F-Score: 3/9
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
PRA Price & Volume
ProAssurance Corporation (PRA) stock price & volume — 10-year historical chart
Loading chart...
PRA Growth Metrics
ProAssurance Corporation (PRA) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years3.63%
5 Years4.36%
3 Years-0.11%
TTM-3.16%
Profit CAGR
10 Years-7.92%
5 Years-
3 Years-
TTM54.14%
EPS CAGR
10 Years-7.29%
5 Years-
3 Years-
TTM50.35%
Return on Capital
10 Years0.94%
5 Years1.6%
3 Years1.79%
Last Year3.97%
PRA Recent Earnings
ProAssurance Corporation (PRA) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 7/12 qtrs (58%)●Beat Revenue 9/12 qtrs (75%)
Q2 2026Latest
May 5, 2026EPS
$0.25
Est $0.25
+0.0%
Revenue
$224M
Est $217M
+3.1%
Q1 2026
Feb 23, 2026EPS
$0.82
Est $0.22
+272.7%
Revenue
$232M
Est $231M
+0.6%
Q4 2025
Nov 4, 2025EPS
$0.15
Est $0.28
-46.4%
Revenue
$275M
Est $261M
+5.3%
Q3 2025
Aug 5, 2025EPS
$0.52
Est $0.19
+173.7%
Revenue
$277M
Est $266M
+4.1%
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 5, 2026 | $0.25vs $0.25+0.0% | $224Mvs $217M+3.1% |
| Q1 2026 | Feb 23, 2026 | $0.82vs $0.22+272.7% | $232Mvs $231M+0.6% |
| Q4 2025 | Nov 4, 2025 | $0.15vs $0.28-46.4% | $275Mvs $261M+5.3% |
| Q3 2025 | Aug 5, 2025 | $0.52vs $0.19+173.7% | $277Mvs $266M+4.1% |
Based on last 12 quarters of dataView full earnings history →
PRA Peer Comparison
ProAssurance Corporation (PRA) competitors in Specialty and excess surplus insurers — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 HCI | 2B | 154.14 | 6.20 | 20.21% | 33.16% | 36.22% | 0.06 | |
 PLMR | 2.94B | 110.75 | 15.45 | 58.16% | 22.56% | 22.79% | 0.01 | |
 ACGL | 33.74B | 94.70 | 8.15 | 14.27% | 22.07% | 19.02% | 0.11 | |
 RLI | 4.51B | 49.01 | 11.24 | 6.33% | 20.8% | 22% | 0.06 | |
 MMC | 85.27B | 174.06 | 21.28 | 7.57% | 15.6% | 26.87% | 1.62 | |
 AJG | 50.63B | 196.91 | 34.25 | 20.66% | 10.72% | 6.5% | 0.60 | |
 HIG | 36.71B | 133.49 | 10.02 | 7.1% | 14.13% | 22.01% | 0.23 | |
 CNA | 11.75B | 43.43 | 9.26 | 5.1% | 8.95% | 11.94% | 0.26 |
Compare PRA vs Peers
ProAssurance Corporation (PRA) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
PRA Income Statement
ProAssurance Corporation (PRA) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 858.12M | 877.08M | 1.01B | 886.86M | 1.08B | 1.1B | 1.13B | 1.13B | 1.1B | 1.08B |
| Revenue Growth % | -2.04% | 2.21% | 15.14% | -12.18% | 21.26% | 2.45% | 2.6% | -0.2% | -2.67% | -3.16% |
| Medical Costs & Claims | 564.91M | 697.71M | 869.25M | 772.01M | 862.85M | 909.94M | 935.31M | 874.87M | 665.42M | 541.83M |
| Medical Cost Ratio % | 65.83% | 79.55% | 86.07% | 87.05% | 80.23% | 82.59% | 82.74% | 77.55% | 60.6% | 50.2% |
| Gross Profit | 293.21M▲ 0% | 179.37M▼ 38.8% | 140.65M▼ 21.6% | 114.85M▼ 18.3% | 212.58M▲ 85.1% | 191.86M▼ 9.7% | 195.11M▲ 1.7% | 253.34M▲ 29.8% | 432.61M▲ 70.8% | 274.81M▲ 0% |
| Gross Margin % | 34.17% | 20.45% | 13.93% | 12.95% | 19.77% | 17.41% | 17.26% | 22.45% | 39.4% | 25.46% |
| Gross Profit Growth % | -14.86% | -38.82% | -21.59% | -18.34% | 85.1% | -9.75% | 1.69% | 29.84% | 70.77% | - |
| Operating Expenses | 164.58M | 150.35M | 169.45M | 331.9M | 65.97M | 198.08M | 234.26M | 190.26M | 360.54M | 268.94M |
| OpEx / Revenue % | 19.18% | 17.14% | 16.78% | 37.42% | 6.13% | 17.98% | 20.72% | 16.86% | 32.84% | 24.92% |
| Depreciation & Amortization | 28.8M | 21.25M | 18.66M | 21.38M | 37.25M | 38.06M | 26.02M | 17.75M | 13.69M | 9.87M |
| Combined Ratio % | 85.01% | 96.69% | 102.85% | 124.47% | 86.37% | 100.56% | 103.46% | 94.41% | 93.44% | 75.12% |
| Operating Income | 128.62M▲ 0% | 29.02M▼ 77.4% | -28.8M▼ 199.2% | -217.06M▼ 653.6% | 146.61M▲ 167.5% | -6.22M▼ 104.2% | -39.15M▼ 529.8% | 63.08M▲ 261.1% | 72.07M▲ 14.3% | 91.12M▲ 0% |
| Operating Margin % | 14.99% | 3.31% | -2.85% | -24.47% | 13.63% | -0.56% | -3.46% | 5.59% | 6.56% | 8.44% |
| Operating Income Growth % | -27% | -77.43% | -199.24% | -653.56% | 167.54% | -104.24% | -529.81% | 261.12% | 14.25% | - |
| EBITDA | 157.42M | 50.28M | -10.14M | -195.68M | 183.85M | 31.85M | -13.13M | 80.83M | 85.76M | 100.99M |
| EBITDA Margin % | 18.34% | 5.73% | -1% | -22.06% | 17.1% | 2.89% | -1.16% | 7.16% | 7.81% | 9.36% |
| Interest Expense | 16.84M | 16.12M | 16.64M | 15.5M | 19.72M | 20.37M | 23.15M | 22.34M | 20.84M | 20.77M |
| Non-Operating Income | -16.84M | -16.12M | -16.64M | -15.5M | -19.72M | -20.37M | -23.15M | -22.34M | -20.84M | -15.68M |
| Pretax Income | 128.62M▲ 0% | 29.02M▼ 77.4% | -28.8M▼ 199.2% | -217.06M▼ 653.6% | 146.61M▲ 167.5% | -6.22M▼ 104.2% | -39.15M▼ 529.8% | 63.08M▲ 261.1% | 72.07M▲ 14.3% | 87.59M▲ 0% |
| Pretax Margin % | 14.99% | 3.31% | -2.85% | -24.47% | 13.63% | -0.56% | -3.46% | 5.59% | 6.56% | 8.12% |
| Income Tax | 21.36M | -18.03M | -29.81M | -41.33M | 2.48M | -5.81M | -545K | 10.33M | 21.15M | 22.21M |
| Effective Tax Rate % | 16.61% | -62.13% | 103.49% | 19.04% | 1.69% | 93.53% | 1.39% | 16.38% | 29.35% | 25.36% |
| Net Income | 107.26M▲ 0% | 47.06M▼ 56.1% | 1M▼ 97.9% | -175.73M▼ 17602.7% | 144.12M▲ 182.0% | -402K▼ 100.3% | -38.6M▼ 9503.0% | 52.74M▲ 236.6% | 50.91M▼ 3.5% | 65.2M▲ 0% |
| Net Margin % | 12.5% | 5.37% | 0.1% | -19.81% | 13.4% | -0.04% | -3.42% | 4.68% | 4.64% | 6.04% |
| Net Income Growth % | -29% | -56.13% | -97.87% | -17602.69% | 182.02% | -100.28% | -9502.99% | 236.63% | -3.47% | 54.14% |
| EPS (Diluted) | 2.00▲ 0% | 0.88▼ 56.0% | 0.02▼ 97.9% | -3.26▼ 17626.9% | 2.67▲ 181.9% | -0.01▼ 100.3% | -0.73▼ 9764.9% | 1.03▲ 241.1% | 0.99▼ 3.9% | 1.26▲ 0% |
| EPS Growth % | -29.33% | -56% | -97.89% | -17626.88% | 181.9% | -100.28% | - | 241.1% | -3.88% | 50.35% |
| EPS (Basic) | 2.01 | 0.88 | 0.02 | -3.26 | 2.67 | -0.01 | -0.73 | 1.03 | 0.99 | - |
| Diluted Shares Outstanding | 53.61M | 53.75M | 53.84M | 53.91M | 54.06M | 54.14M | 52.79M | 51.27M | 51.67M | 51.81M |
PRA Balance Sheet
ProAssurance Corporation (PRA) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | 4.93B | 4.6B | 4.81B | 4.65B | 6.19B | 5.7B | 5.63B | 5.57B | 5.45B | 5.41B |
| Asset Growth % | -2.68% | -6.66% | 4.45% | -3.14% | 33.01% | -7.94% | -1.19% | -1.02% | -2.28% | -9.74% |
| Total Investment Assets | 503.55M | 466.14M | 3.42B | 3.42B | 8.7B | 4.42B | 420.78M | 4.4B | 4.44B | 4M |
| Long-Term Investments | 503.55M | 466.14M | 3.29B | 3.27B | 4.64B | 512.69M | 420.78M | 376.56M | 349.71M | 1.06B |
| Short-Term Investments | 0 | 0 | 2.63B | 2.8B | 4.05B | 3.72B | 0 | 4.02B | 4.09B | 309.51M |
| Total Current Assets | 134.5M | 80.47M | 0 | 0 | 4.93B | 0 | 541.25M | 0 | 4.74B | 561.08M |
| Cash & Equivalents | 134.5M | 80.47M | 175.37M | 215.78M | 143.6M | 29.96M | 65.9M | 54.88M | 36.49M | 14.05M |
| Receivables | 0 | 0 | 652.99M | 600.85M | 707.43M | 693.3M | 235.57M | 656.2M | 582.04M | 2.09B |
| Other Current Assets | 0 | 0 | -3.5B | -3.65B | 0 | -4.47B | 239.78M | -4.58B | 0 | 0 |
| Goodwill & Intangibles | 293.73M | 287.52M | 281.48M | 115.33M | 122.95M | 116.41M | 65.8M | 59.7M | 111.44M | 396.43M |
| Goodwill | 210.72M | 210.72M | 210.72M | 49.61M | 49.61M | 49.61M | 5.5M | 5.5M | 5.5M | 5.5M |
| Intangible Assets | 83M | 76.8M | 70.76M | 65.72M | 73.34M | 66.8M | 60.31M | 54.2M | 105.94M | 47.61M |
| PP&E (Net) | 0 | 0 | 21.07M | 19.01M | 19.59M | 18.99M | 46.03M | 16.51M | 13.82M | 0 |
| Other Assets | 72.81M | 155.74M | -3.59B | -3.41B | 0 | -648.09M | 3.9B | -452.78M | 106.16M | 0 |
| Total Liabilities | 3.33B | 3.08B | 3.29B | 3.31B | 4.76B | 4.6B | 4.52B | 4.37B | 4.1B | 4.08B |
| Total Debt | 411.81M | 287.76M | 307.87M | 304.83M | 445.83M | 446.99M | 444.31M | 442.26M | 435.06M | 13.98M |
| Net Debt | 277.32M | 207.29M | 132.5M | 89.05M | 302.23M | 417.03M | 378.41M | 387.38M | 398.57M | -78K |
| Long-Term Debt | 410.42M | 287.76M | 285.82M | 284.71M | 424.99M | 426.98M | 427.13M | 299.87M | 295.42M | 0 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 3.29M | 125M | 125M | 13.98M |
| Total Current Liabilities | 0 | 0 | 0 | 0 | 22.63M | 0 | 2.96B | 3.83B | 3.56B | 13.98M |
| Accounts Payable | 37.73M | 55.61M | 52.95M | 40M | 22.63M | 28.51M | 24.02M | 27.29M | 14.42M | 0 |
| Deferred Revenue | 0 | -1.45M | 0 | 0 | 0 | 422.95M | 0 | 418.76M | 403.88M | 0 |
| Other Current Liabilities | -351.94M | -151.22M | -125.39M | -108.86M | 0 | -451.46M | 2.93B | 3.26B | 3.02B | 0 |
| Deferred Taxes | 1000K | 0 | 0 | 0 | 0 | 0 | 1000K | 0 | 0 | -98.98M |
| Other Liabilities | 2.91B | 2.79B | -307.87M | -304.83M | 4.32B | 226.38M | 619.18M | 226.52M | 226.3M | 4.16B |
| Total Equity | 1.59B▲ 0% | 1.52B▼ 4.5% | 1.51B▼ 0.7% | 1.35B▼ 10.8% | 1.43B▲ 5.9% | 1.1B▼ 22.7% | 1.11B▲ 0.7% | 1.2B▲ 8.1% | 1.35B▲ 12.3% | 1.34B▲ 0% |
| Equity Growth % | -11.34% | -4.5% | -0.73% | -10.76% | 5.87% | -22.71% | 0.72% | 8.07% | 12.26% | 39.33% |
| Shareholders Equity | 1.59B | 1.52B | 1.51B | 1.35B | 1.43B | 1.1B | 1.11B | 1.2B | 1.35B | 1.34B |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | 1.61B | 1.57B | 1.51B | 1.3B | 1.43B | 1.42B | 1.38B | 1.43B | 1.49B | 1.49B |
| Common Stock | 628K | 630K | 631K | 632K | 633K | 634K | 636K | 638K | 640K | 642K |
| Accumulated OCI | 14.91M | -16.91M | 36.95M | 75.23M | 16.28M | -298.61M | -204.49M | -172.39M | -81.05M | 0 |
| Return on Equity (ROE) | 6.32% | 3.02% | 0.07% | -12.28% | 10.38% | -0.03% | -3.48% | 4.56% | 3.99% | 4.95% |
| Return on Assets (ROA) | 2.15% | 0.99% | 0.02% | -3.72% | 2.66% | -0.01% | -0.68% | 0.94% | 0.92% | 1.19% |
| Equity / Assets | 32.35% | 33.1% | 31.46% | 28.99% | 23.07% | 19.37% | 19.74% | 21.56% | 24.77% | 24.72% |
| Debt / Equity | 0.26x | 0.19x | 0.20x | 0.23x | 0.31x | 0.40x | 0.40x | 0.37x | 0.32x | 0.32x |
| Book Value per Share | 29.75 | 28.34 | 28.08 | 25.03 | 26.42 | 20.39 | 21.07 | 23.44 | 26.11 | 25.84 |
| Tangible BV per Share | 24.27 | 22.99 | 22.85 | 22.89 | 24.15 | 18.24 | 19.82 | 22.28 | 23.95 | 24.81 |
PRA Cash Flow Statement
ProAssurance Corporation (PRA) cash flow — operating, investing & free cash flow history
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 173.39M | 177.26M | 148.17M | 92.34M | 73.97M | -29.84M | -49.88M | -10.71M | -25.62M | -25.62M |
| Operating CF Growth % | -3.13% | 2.24% | -16.42% | -37.68% | -19.9% | -140.34% | -67.17% | 78.52% | -139.1% | -5347.13% |
| Operating CF / Revenue % | 20.21% | 20.21% | 14.67% | 10.41% | 6.88% | -2.71% | -4.41% | -0.95% | -2.33% | -2.37% |
| Net Income | 107.26M | 47.06M | 1M | -175.73M | 144.12M | -402K | -38.6M | 52.74M | 50.91M | 65.2M |
| Depreciation & Amortization | 28.8M | 21.25M | 18.66M | 21.38M | 37.25M | 38.06M | 26.02M | 17.75M | 13.69M | 9.87M |
| Stock-Based Compensation | 10.62M | 5.32M | 3.53M | 3.84M | 4.39M | 4.83M | 5.25M | 6.2M | 7.85M | 6.06M |
| Deferred Taxes | 0 | -11.82M | -28.64M | -21.15M | 1.32M | -6.62M | -1.77M | 12.82M | 16.79M | 16.78M |
| Other Non-Cash Items | -3.68M | 61.09M | -25.26M | 203.07M | -126.01M | 58.79M | 41.17M | -4.28M | 11.27M | 12.24M |
| Working Capital Changes | 30.39M | 54.37M | 178.87M | 60.93M | 12.9M | -124.5M | -81.94M | -95.96M | -126.13M | -115.69M |
| Cash from Investing | 200.28M | 214.9M | 50.52M | -8.48M | -85.53M | -62M | 141.14M | 10.67M | 19.44M | 15.33M |
| Capital Expenditures | 0 | -9.64M | -9.59M | -7.48M | -3.84M | -4.35M | -4.79M | -9.02M | -3.6M | -2.87M |
| Acquisitions | -42.69M | -70.82M | 216.7M | 0 | 0 | 0 | 0 | 39.68M | 19.38M | -924K |
| Purchase of Investments | -915.35M | -1.05B | -770.19M | 0 | -1.51B | -681.25M | -464.94M | -798.44M | -924.07M | -132.22M |
| Sale/Maturity of Investments | 1.11B | 1.07B | 597.59M | 0 | 1.35B | 656.2M | 586.17M | 778.45M | 907.45M | 129.95M |
| Other Investing | 50.35M | 282.18M | 16M | -1.01M | 78.31M | -32.59M | 24.69M | 0 | 20.27M | 21.39M |
| Cash from Financing | -356.51M | -446.19M | -103.79M | -43.45M | -60.62M | -21.8M | -55.31M | -10.97M | -12.2M | -13.87M |
| Dividends Paid | -315.23M | -316.48M | -93.2M | -38.66M | -10.76M | -10.77M | -5.38M | 0 | 0 | 0 |
| Share Repurchases | 0 | -1M | 0 | -2.35M | -10.38M | -3.25M | -50.49M | 0 | 0 | -1.2M |
| Stock Issued | 0 | 0 | 0 | 2.35M | 10.38M | 0 | 0 | 8K | 0 | 0 |
| Debt Issuance (Net) | -1000K | -1000K | -1000K | -1000K | -1000K | 0 | 0 | -1000K | -1000K | -3M |
| Other Financing | -4.75M | -5.31M | -9.14M | -935K | -3.38M | -7.79M | 552K | -6.29M | -5.95M | -7.98M |
| Net Change in Cash | 17.15M▲ 0% | -54.02M▼ 415.0% | 94.9M▲ 275.7% | 40.41M▼ 57.4% | -72.18M▼ 278.6% | -113.64M▼ 57.4% | 35.94M▲ 131.6% | -11.02M▼ 130.7% | -18.39M▼ 66.9% | -29.49M▲ 0% |
| Exchange Rate Effect | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash at Beginning | 117.35M | 134.5M | 80.47M | 175.37M | 215.78M | 143.6M | 29.96M | 65.9M | 54.88M | 36.49M |
| Cash at End | 134.5M | 80.47M | 175.37M | 215.78M | 143.6M | 29.96M | 65.9M | 54.88M | 36.49M | 14.05M |
| Free Cash Flow | 162.9M▲ 0% | 167.63M▲ 2.9% | 138.58M▼ 17.3% | 84.86M▼ 38.8% | 70.13M▼ 17.4% | -34.19M▼ 148.8% | -54.67M▼ 59.9% | -19.73M▲ 63.9% | -29.22M▼ 48.1% | -16.88M▲ 0% |
| FCF Growth % | -3.07% | 2.9% | -17.33% | -38.76% | -17.36% | -148.76% | -59.9% | 63.91% | -48.08% | 11.54% |
| FCF Margin % | 18.98% | 19.11% | 13.72% | 9.57% | 6.52% | -3.1% | -4.84% | -1.75% | -2.66% | -1.56% |
| FCF per Share | 3.04 | 3.12 | 2.57 | 1.57 | 1.3 | -0.63 | -1.04 | -0.38 | -0.57 | -0.57 |
PRA Key Ratios
ProAssurance Corporation (PRA) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Combined Ratio | 85.01% | 96.69% | 102.85% | 124.47% | 86.37% | 100.56% | 103.46% | 94.41% | 93.44% | 75.12% |
| Medical Cost Ratio | 65.83% | 79.55% | 86.07% | 87.05% | 80.23% | 82.59% | 82.74% | 77.55% | 60.6% | 50.2% |
| Return on Equity (ROE) | 6.32% | 3.02% | 0.07% | -12.28% | 10.38% | -0.03% | -3.48% | 4.56% | 3.99% | 4.95% |
| Return on Assets (ROA) | 2.15% | 0.99% | 0.02% | -3.72% | 2.66% | -0.01% | -0.68% | 0.94% | 0.92% | 1.19% |
| Equity / Assets | 32.35% | 33.1% | 31.46% | 28.99% | 23.07% | 19.37% | 19.74% | 21.56% | 24.77% | 24.72% |
| Book Value / Share | 29.75 | 28.34 | 28.08 | 25.03 | 26.42 | 20.39 | 21.07 | 23.44 | 26.11 | 25.84 |
| Debt / Equity | 0.26x | 0.19x | 0.20x | 0.23x | 0.31x | 0.40x | 0.40x | 0.37x | 0.32x | 0.32x |
| Revenue Growth | -2.04% | 2.21% | 15.14% | -12.18% | 21.26% | 2.45% | 2.6% | -0.2% | -2.67% | -3.16% |
PRA SEC Filings & Documents
ProAssurance Corporation (PRA) SEC filings — annual & quarterly reports (10-K, 10-Q)
PRA Frequently Asked Questions
ProAssurance Corporation (PRA) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
ProAssurance Corporation (PRA) saw revenue decline by 2.7% over the past year.
Yes, ProAssurance Corporation (PRA) is profitable, generating $65.2M in net income for fiscal year 2025 (4.6% net margin).
Dividend & Returns
ProAssurance Corporation (PRA) has a return on equity (ROE) of 4.0%. This is below average, suggesting room for improvement.
Industry Metrics
ProAssurance Corporation (PRA) has a combined ratio of 93.4%. A ratio below 100% indicates underwriting profitability.
Explore More PRA
ProAssurance Corporation (PRA) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates